Sartorius expands biopharma manufacturing in Slovenia

By The Science Advisory Board staff writers

May 28, 2021 -- Sartorius plans to expand production facilities for purification products for vaccines and therapies at its facility in Ajdovscina, Slovenia.

The manufacturing and lab space will more than double from 3,000 sq m to 6,200 sq m. In 2021, the company will invest more than 400 million euros ($487.9 million U.S.) in manufacturing capacities around the world to keep up with demand.

Researchers innovate drug discovery screening techniques
Researchers from around the globe gathered to discuss innovations in laboratory techniques such as phenotypic profiling and flow cytometry for drug discovery...
Sartorius contributes to Penn State cell culture facility
Sartorius Stedim Biotech has donated $1.5 million to Pennsylvania State University (Penn State) for the creation of the Sartorius Cell Culture Facility,...
Sartorius to acquire Novasep's chromatography division
Sartorius has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.
Sartorius acquires WaterSep BioSeparations
Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023...
Sartorius expands small sample filtration to 50mL
The new Sartolab RF 50 vacuum filtration units are available in two versions, one with an asymmetric 0.22 µm PES membrane for sterile filtration...

Copyright © 2021 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter